Exact Mass: 612.1268

Exact Mass Matches: 612.1268

Found 35 metabolites which its exact mass value is equals to given mass value 612.1268, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cefpiramide

(6R,7R)-7-[(2R)-2-[(4-hydroxy-6-methylpyridin-3-yl)formamido]-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C25H24N8O7S2 (612.1209)


Cefpiramide is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic. The bactericidal activity of cefpiramide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Myricetin 3-sambubioside

myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside

C26H28O17 (612.1326)


   

Pentagrametin

Pentagrametin

C33H24O12 (612.1268)


   

myricetin 3-O-beta-D-xylopyranosyl(1*2)-beta-D-glucopyranoside

myricetin 3-O-beta-D-xylopyranosyl(1*2)-beta-D-glucopyranoside

C26H28O17 (612.1326)


   

Mesuabixanthone A

Mesuabixanthone A

C33H24O12 (612.1268)


   
   

4,4,5,5-tetrahydroxy-6,6,3-trimethoxy-[C7-O-C7]-biflavone

4,4,5,5-tetrahydroxy-6,6,3-trimethoxy-[C7-O-C7]-biflavone

C33H24O12 (612.1268)


   
   

acremoxanthone B

acremoxanthone B

C33H24O12 (612.1268)


   

myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside

3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

C26H28O17 (612.1326)


   

Cefpiramide

Cefpiramide acid

C25H24N8O7S2 (612.1209)


A third-generation cephalosporin antibiotic with [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl and (R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It has a broad spectrum of antibacterial activity. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

THEOPHYLLINE METHOXYOXIMERCURI-PROPYL SUCCINYLUREA

THEOPHYLLINE METHOXYOXIMERCURI-PROPYL SUCCINYLUREA

C16H22HgN6O7 (612.1256)


   

disodium 3,3-[carbonylbis[imino(3-methoxy-4,1-phenylene)azo]]dibenzoate

disodium 3,3-[carbonylbis[imino(3-methoxy-4,1-phenylene)azo]]dibenzoate

C29H22N6Na2O7 (612.1345)


   

hydrogen 9-(2-carboxylatophenyl)-3-(2-methylanilino)-6-(2-methyl-4-sulphoanilino)xanthylium, monosodium salt

hydrogen 9-(2-carboxylatophenyl)-3-(2-methylanilino)-6-(2-methyl-4-sulphoanilino)xanthylium, monosodium salt

C34H25N2NaO6S (612.1331)


   

2-[4,5-bis(pentylsulfanyl)-1,3-dithiol-2-ylidene]-4,5-bis(pentylsulfanyl)-1,3-dithiole

2-[4,5-bis(pentylsulfanyl)-1,3-dithiol-2-ylidene]-4,5-bis(pentylsulfanyl)-1,3-dithiole

C26H44S8 (612.1209)


   

sodium 2-[3-(4-sulfonato-o-tolyliminio)-6-o-toluidino-3H-xanthen-9-yl]benzoate

sodium 2-[3-(4-sulfonato-o-tolyliminio)-6-o-toluidino-3H-xanthen-9-yl]benzoate

C34H25N2NaO6S (612.1331)


   

CMP-N-acetyl-beta-neuraminate(2-)

CMP-N-acetyl-beta-neuraminate(2-)

C20H29N4O16P-2 (612.1316)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

6-[4-[3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[4-[3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H28O17 (612.1326)


   

6-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H28O17 (612.1326)


   

CMP-N-acetyl-beta-neuraminate(2-)

CMP-N-acetyl-beta-neuraminate(2-)

C20H29N4O16P (612.1316)


Dianion of CMP-N-acetyl-beta-neuraminate arising from deprotonation of carboxylic acid and phosphate functions; major species at pH 7.3.

   

3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

C26H28O17 (612.1326)


   

3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

C26H28O17 (612.1326)


   

3-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

3-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

C26H28O17 (612.1326)


   

(2s)-2-[(1e)-2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one

(2s)-2-[(1e)-2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one

C33H24O12 (612.1268)


   

[(3r,4r)-3-amino-2,4-dihydroxy-3-(hydroxymethyl)-5-oxocyclopent-1-en-1-yl]oxy([(2r,3s,4r,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-3-{[(3r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxolan-2-yl]methoxy)phosphinic acid

[(3r,4r)-3-amino-2,4-dihydroxy-3-(hydroxymethyl)-5-oxocyclopent-1-en-1-yl]oxy([(2r,3s,4r,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-3-{[(3r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxolan-2-yl]methoxy)phosphinic acid

C20H29N4O16P (612.1316)


   

methyl (1s,17s,19s,27s)-27-(acetyloxy)-10,15,19,22-tetrahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate

methyl (1s,17s,19s,27s)-27-(acetyloxy)-10,15,19,22-tetrahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate

C33H24O12 (612.1268)


   

2-[(1e)-2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one

2-[(1e)-2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one

C33H24O12 (612.1268)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}chromen-4-one

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}chromen-4-one

C26H28O17 (612.1326)


   

3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

C26H28O17 (612.1326)


   

2-[2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one

2-[2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one

C33H24O12 (612.1268)


   

methyl 27-(acetyloxy)-10,15,19,22-tetrahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate

methyl 27-(acetyloxy)-10,15,19,22-tetrahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate

C33H24O12 (612.1268)


   

3-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

3-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one

C26H28O17 (612.1326)


   

3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-{[3,5,7-trihydroxy-2-(4-methoxyphenyl)-4-oxochromen-8-yl]methyl}chromen-4-one

3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-{[3,5,7-trihydroxy-2-(4-methoxyphenyl)-4-oxochromen-8-yl]methyl}chromen-4-one

C33H24O12 (612.1268)


   

5-hydroxy-7-{[5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxy}-2-(4-hydroxy-3-methoxyphenyl)-6-methoxychromen-4-one

5-hydroxy-7-{[5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxy}-2-(4-hydroxy-3-methoxyphenyl)-6-methoxychromen-4-one

C33H24O12 (612.1268)


   

9-hydroxy-7,12-dimethoxy-2-methyl-2-[(1e)-2-(1,3,5-trihydroxy-9-oxoxanthen-2-yl)ethenyl]-3h-1,4,5-trioxatetraphen-10-one

9-hydroxy-7,12-dimethoxy-2-methyl-2-[(1e)-2-(1,3,5-trihydroxy-9-oxoxanthen-2-yl)ethenyl]-3h-1,4,5-trioxatetraphen-10-one

C33H24O12 (612.1268)